BNY Mellon Funds Announce "Change in Control" of Alcentra NY, LLC, the Funds' Sub-Adviser
As a result of the Transaction, there will be a "change in control" of Alcentra, which will effect an assignment and automatic termination of each Current Sub-Advisory Agreement, pursuant to its terms and the applicable provisions of the Investment Company Act of 1940, as amended, as of the Closing Date. Consequently, each Fund's Board will be asked to approve a new sub-advisory agreement (each, a "New Sub-Advisory Agreement") between BNYM Investment Adviser and Alcentra, with respect to the applicable Fund, and call a Special Meeting of Shareholders to seek shareholder approval of a New Sub-Advisory Agreement. In addition, each Fund's Board will be asked to approve an interim sub-advisory agreement (an "Interim Sub-Advisory Agreement") between BNYM Investment Adviser and Alcentra, with respect to the applicable Fund, which would take effect in the event that the Transaction is effected before shareholder approval of the applicable New Sub-Advisory Agreement is obtained, and each Fund would continue to solicit shareholder approval of the applicable New Sub-Advisory Agreement while the applicable Interim Sub-Advisory Agreement is in place. Each New Sub-Advisory Agreement and Interim Sub-Advisory Agreement is intended to ensure that Alcentra can provide uninterrupted service as sub-adviser to each Fund after the Closing Date. If an Interim Sub-Advisory Agreement goes into effect, it would expire the earlier of 150 days after the Closing Date of the Transaction or upon shareholder approval of the applicable New Sub-Advisory Agreement.
There will be no increase in the advisory fee payable by the Funds to BNYM Investment Adviser as a consequence of the Transaction and the sub-advisory fee payable by BNYM Investment Adviser to Alcentra under each New Sub-Advisory Agreement and each Interim Sub-Advisory Agreement will be the same as that payable by BNYM Investment Adviser to Alcentra under the applicable Current Sub-Advisory Agreement. Each New Sub-Advisory Agreement and Interim Sub-Advisory Agreement is substantially similar in material respects to the applicable Current Sub-Advisory Agreement and each Fund's investment strategy, management policies and portfolio managers currently are not expected to change in connection with the implementation of either agreement.
This press release is not a solicitation of any proxy. A proxy statement further describing the Transaction and the applicable New Sub-Advisory Agreement and requesting that shareholders of the applicable Fund vote to approve the applicable New Sub-Advisory Agreement will be mailed to shareholders of record at a later date. Shareholders should read the proxy materials carefully when they are available because they contain important information about
Important Information
This release is for informational purposes only and should not be considered as investment advice or a recommendation of any particular security.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220531005655/en/
For Press Inquiries:
(212) 635-6027
For Other Inquiries:
The National Marketing Desk
1-800-334-6899
Source: